Search - tctmd.com

Displaying 201 - 220 of 261

Sort: Relevancy | Date

Presentation TCT 2014

Cost Comparisons of Invasive and Non-Invasive Diagnostic Evaluations for Patients with Suspected In-Stent Restenosis Following Implant of Metallic Stents and Bioresorbable___

Presenter: James Min

September 16, 2014

Presentation TCT 2014

Case #7: In-Stent Restenosis

Presenter: Soo-Jin Kang, Akiko Maehara, Gary S. Mintz, Bernhard Witzenbichler

September 15, 2014

Presentation TCT 2014

Mechanisms, Predictors, and Unusual Causes of In-Stent Restenosis

Presenter: Soo-Jin Kang, Akiko Maehara, Gary S. Mintz, Lisette Okkels Jensen

September 15, 2014

Presentation TCT 2014

DCB Use in the Real World I: In-Stent Restenosis Insights From the FAIR Trial

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri

September 15, 2014

Presentation TCT 2014

TCT 270: Comparison Among a Drug-Eluting Balloon, Drug-Eluting Stent, and Plain Balloon Angioplasty for Treatment of In-Stent Restenosis: A Network Meta-analysis of 11 Randomized Controlled Trials

Presenter: John A. Bittl, Tullio Palmerini, Joo Myung Lee, MD

September 15, 2014

Presentation TCT 2014

RIBS IV: A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with Coronary In-Stent Restenosis of Drug-Eluting Stents

Presenter: Gregg W. Stone, Pieter C. Smits, Fernando Alfonso

September 14, 2014

Presentation TCT 2014

Excimer Laser for Femoropopliteal In-Stent Restenosis: Light at the End of the Tunnel?

Presenter: John R. Laird Jr, Daniel J. McCormick, Dmitriy N. Feldman, Carlos I. Mena-Hurtado

September 13, 2014

Presentation TCT 2014

TCT 267: Lower Mortality of Paclitaxel-Coated Balloon Compared with Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis: Two-Year Follow-up of the PEPCAD China ISR Trial

Presenter: Run-Lin Gao, Jochen Wöhrle, Bruno Scheller, Yelin Zhao

September 13, 2014

Presentation TCT 2014

DCB in BMS vs DES ISR: Insights from the RIBS Trials

Presenter: Run-Lin Gao, Jochen Wöhrle, Bruno Scheller, Fernando Alfonso

September 13, 2014

Presentation TCT 2014

Approach to In-Stent Restenosis in 2014: DCB or DES?

Presenter: Run-Lin Gao, Jochen Wöhrle, Bruno Scheller, Robert A. Byrne

September 13, 2014

Presentation TCT 2014

Consensus and Take-home Messages

Presenter: Alejandro Cherro, Carlo Di Mario, Hervé Le Breton

September 13, 2014

Presentation TCT 2014

How Did I Treat This Case?

Presenter: Alejandro Cherro, Carlo Di Mario, Hervé Le Breton, Alejandro D Fernandez

September 13, 2014

Presentation TCT 2014

How Would I Treat This Case?

Presenter: Alejandro Cherro, Carlo Di Mario, Hervé Le Breton, Eric Van Belle

September 13, 2014

Presentation TCT 2014

Case #2: A Challenging Restenosis Lesion

Presenter: Alejandro Cherro, Carlo Di Mario, Hervé Le Breton, Alejandro D Fernandez

September 13, 2014

Presentation TCT 2014

Consensus and Take-home Messages

Presenter: Alejandro Cherro, Carlo Di Mario, Hervé Le Breton

September 13, 2014

Presentation TCT 2014

How Did I Treat This Case?

Presenter: Alejandro Cherro, Carlo Di Mario, Hervé Le Breton, Jacques Berland

September 13, 2014

Presentation TCT 2014

How Would I Treat This Case?

Presenter: Alejandro Cherro, Carlo Di Mario, Hervé Le Breton, Miguel A Larribau

September 13, 2014

Presentation TCT 2014

Case #1: Restenosis in an Unusual Venous Bypass Bifurcated Lesion

Presenter: Alejandro Cherro, Carlo Di Mario, Hervé Le Breton, Jacques Berland

September 13, 2014

Presentation

The Efficacy of “Hybrid” PCI in CTOs Caused by In-Stent Restenosis

Presenter: G. Christopoulos

July 14, 2014

Presentation Physiology and Intravascular Imaging 2014

Mechanisms and Predictors of In-stent Restenosis and Stent Thrombosis

Presenter: Soo-Jin Kang

March 27, 2014

Advertisement

Cost Comparisons of Invasive and Non-Invasive Diagnostic Evaluations for Patients with Suspected In-Stent Restenosis Following Implant of Metallic Stents and Bioresorbable___

Case #7: In-Stent Restenosis

Mechanisms, Predictors, and Unusual Causes of In-Stent Restenosis

DCB Use in the Real World I: In-Stent Restenosis Insights From the FAIR Trial

TCT 270: Comparison Among a Drug-Eluting Balloon, Drug-Eluting Stent, and Plain Balloon Angioplasty for Treatment of In-Stent Restenosis: A Network Meta-analysis of 11 Randomized Controlled Trials

RIBS IV: A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with Coronary In-Stent Restenosis of Drug-Eluting Stents

Excimer Laser for Femoropopliteal In-Stent Restenosis: Light at the End of the Tunnel?

TCT 267: Lower Mortality of Paclitaxel-Coated Balloon Compared with Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis: Two-Year Follow-up of the PEPCAD China ISR Trial

DCB in BMS vs DES ISR: Insights from the RIBS Trials

Approach to In-Stent Restenosis in 2014: DCB or DES?

Consensus and Take-home Messages

How Did I Treat This Case?

How Would I Treat This Case?

Case #2: A Challenging Restenosis Lesion

Consensus and Take-home Messages

How Did I Treat This Case?

How Would I Treat This Case?

Case #1: Restenosis in an Unusual Venous Bypass Bifurcated Lesion

The Efficacy of “Hybrid” PCI in CTOs Caused by In-Stent Restenosis

Mechanisms and Predictors of In-stent Restenosis and Stent Thrombosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content